INVOKAMET (CANAGLIFLOZIN/METFORMIN)

Invokamet is a brand-prescribed medication used for the treatment of high blood sugar or Diabetes. It contains two active ingredients: Canagliflozin and Metformin. Invokamet provides people with type 2 diabetes with the advantages of both medications by combining Canagliflozin and Metformin into a single prescription.

Invokamet lowers blood sugar levels by increasing the excretion of glucose in the urine which enhances glycemic control and decreases glucose synthesis in the liver. Let us know more about Invokamet cost and where to buy Invokamet online.

One of the active components of Invokamet, Canagliflozin, is a member of the SGLT2 inhibitor drug class. It functions by preventing the kidneys from reabsorbing glucose, or sugar, which increases the amount of glucose excreted in the urine.

The other active component of Invokamet, Metformin, is a member of the biguanide drug class that lowers blood sugar levels by enhancing muscle cell insulin sensitivity and reducing the liver's synthesis of glucose.

Invokamet provides dual-action therapy that addresses various elements of glucose metabolism by combining an SGLT2 inhibitor (Canagliflozin) with a biguanide (Metformin). This combination leads to more thorough and effective blood sugar management than would be possible with either medicine alone.

Invokamet comes in several strengths, all of which are measured in milligrams(mg). It is available in different strengths based on the product of the country, its precise manufacturer’s formulation, and dosage.

The common strengths that are available are:

• Canagliflozin 50 mg/Metformin 500 mg
• Canagliflozin 50 mg/Metformin 850 mg
• Canagliflozin 50 mg/Metformin 1000 mg
• Canagliflozin 150 mg/Metformin 500 mg
• Canagliflozin 150 mg/Metformin 850 mg
• Canagliflozin 150 mg/Metformin 1000 mg

The main purpose of the drug Invokamet is to treat type 2 diabetes. Other benefits and uses of Invokamet are:

• Glycemic control: Invokamet targets several components of glucose metabolism to help people with type 2 diabetes lower their blood sugar levels.
• Weight management: Over time, canagliflozin may help reduce weight by causing calorie loss through the excretion of glucose in the urine.
• Cardiovascular protection: Patients with type 2 diabetes and established cardiovascular disease have a lower chance of major adverse cardiovascular events (such as heart attacks, strokes, and cardiovascular deaths) when taking canagliflozin, according to clinical trials.
• Invokamet is a type of combination drug that provides dual-action therapy that addresses various elements of glucose metabolism by combining an SGLT2 inhibitor (canagliflozin) with a biguanide (metformin). This combination leads to more thorough and effective blood sugar management than would be possible with either medicine alone.
• Simplified treatment plan: Invokamet provides the convenience of a single tablet containing two active components for people with type 2 diabetes who need to take numerous drugs to achieve optimal glycemic control.

• Invokamet dose recommendations vary on the patient's medical history, present state of health, renal function, blood sugar levels, and reaction to therapy.
• Take Invokamet exactly as a healthcare professional directs and adhere to the dose guidelines supplied.
• To reduce gastrointestinal side effects including nausea or diarrhea, Invokamet is often given orally, once or twice a day with meals.
• Your doctor will choose the most effective Invokamet dosage for your needs. He or she may also decide to change the dosage based on kidney function, your reaction to therapy, and any possible adverse effects.
• Never change the dosage or cease taking Invokamet without first speaking with your doctor.

• Oral administration is the method used to administer Invokamet (canagliflozin/metformin). It comes in tablet form, which is taken orally along with water.
• Taking Invokamet tablets with meals once or twice daily helps reduce gastrointestinal side effects like nausea and diarrhea.
• For those with type 2 diabetes who need medicine to control their blood sugar levels, the oral method of administration is convenient and simple to use.

Common side effects of Invokamet include:

• Urinary tract infections or yeast infections in the genitalia.
• Increased thirst.
• Dry mouth.
• Weakness
• Dizziness
• Kidney issues.
• Hypoglycemia
• Nausea
• Diarrhea
• Pain in the abdomen.
• Appetite loss.
• Fractures of the bones.
• Ketoacidosis

Furthermore, get medical help right away if you exhibit any of the symptoms like:

• Allergic response including rash, itching, swelling, extreme dizziness, or trouble breathing.
• Severe hallucinations.
• Heart-related problems such as extremely uncommon heart valve problems or arrhythmias.

Several possible medication interactions associated with Invokamet include:

• Urine output may be increased by Invokamet. There may be an additional impact that increases dehydration and electrolyte imbalances when used with diuretics, which also increases urine production.
• An increased risk of hypotension (low blood pressure) may result from canagliflozin's enhancement of the blood pressure-lowering effects of angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors.
• Canagliflozin may raise the risk of hypoglycemia (low blood sugar) by amplifying the effects of insulin and insulin secretagogues (such as sulfonylureas).
• When canagliflozin and corticosteroids are taken together, blood glucose levels may rise, thereby decreasing the effectiveness of diabetes treatment.
• When used with NSAIDs, canagliflozin may raise the risk of renal issues and dehydration.
• Canagliflozin may affect the metabolism of drugs that are substrates of cytochrome P450 (CYP) enzymes, such as CYP2C8 and CYP3A4. Concomitant use with these drugs may require dosage adjustments or close monitoring for potential drug interactions.